Interview with Carol M Mangione, MD MSPH, USPSTF member and coauthor of Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement

Audio at 5:55 was changed to reflect a revised risk increase statement.

Interview with Michael J. Barry, MD, USPSTF member and coauthor of Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement

Interview with Anna D. Sinaiko, Ph. D., author of What Is the Value of Market-Wide Health Care Price Transparency?

Interview with Benjamin Daniel Sommers, MD, PhD, author of Medicaid Expansion and Health: Assessing the Evidence After Five Years

Interview with Frank B. Hu, MD, PhD, author of Can Plant-Based Meat Alternatives Be Part of a Healthy and Sustainable Diet?

Interview with Francisco G. Cigarroa, MD, author of The Advancing American Kidney Health Executive Order: An Opportunity to Enhance Organ Donation

Interview with S Claiborne Johnston, MD, PhD, author of The Risk and Cost of Limited Clinician and Patient Accountability in Health Care

Interview with William H. Shrank, MD, MSHS, author of Waste in the US Health Care System: Estimated Costs and Potential for Savings

Interview with Pascale Carayon, PhD, author of Improving the System to Support Clinician Well-being and Provide Better Patient Care

Interview with Amol S. Navathe, MD, PhD, author of Addressing Bias in Artificial Intelligence in Health Care

Interview with Mark D. Huffman, MD, MPH, author of Implementation Strategies for Cardiovascular Polypills

Interview with Donna Michelle Zulman, MD, and Abraham Verghese, MD, authors of Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter

Interview with Maya M. Hammoud, MD, MBA, author of Improving the Residency Application and Selection Process: An Optional Early Result Acceptance Program

Interview with I Glenn. Cohen, JD, author of Ethical and Legal Aspects of Ambient Intelligence in Hospitals

Interview with Jack Resneck, MD, author of Refocusing Medication Prior Authorization on Its Intended Purpose

Interview with Martin A. Makary, MD, MPH, author of Billing Quality Is Medical Quality

Interview with Jenny A. Doust, BMBS, author of Potential Consequences of Changing Disease Classifications

Interview with Ezekiel J. Emanuel, M.D., Ph.D., author of The Inevitable Reimagining of Medical Education

Interview with Jonathan A. Patz, MD, MPH, author of A Low-Carbon Future Could Improve Global Health and Achieve Economic Benefits

Hospitals need ways to make rational, fair decisions about who gets ICU beds and ventilators if COVID-19 patients overwhelm capacity. Douglas B. White, MD, MAS, Director of the Program on Ethics and Decision Making in Critical Illness at the University of Pittsburgh, discusses a framework for those decisions and a guideline he helped develop for allocation of scarce resources in public health emergencies.

Noninvasive ventilation (NIV), working with dying patients’ families, use of experimental therapies, and more. JAMA Associate Editor Derek Angus, MD, MPH, Distinguished Professor and Chair of Critical Care Medicine at the University of Pittsburgh, provides a COVID-19 ICU management update.

Watch the recording of this livestream

Questions about testing, chloroquine toxicity, duration of immunity and reinfection, and what to expect next are gripping the US as the novel coronavirus spreads. JAMA Associate Editor Preeti Malani, MD, professor of medicine and Chief Health Officer at the University of Michigan, discusses recent developments in a live conversation with JAMA Editor in Chief Howard Bauchner. Recorded on April 6, 2020.

Interview with Jeffrey A. Linder, MD, author of Delayed Antibiotic Prescriptions in Ambulatory Care: Reconsidering a Problematic Practice

Interview with Madison Kilbride, PhD, author of The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad

Interview with Aaron S. Kesselheim, MD, JD, MPH, author of Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials

The US spends more on health care as a proportion of its GDP than any other nation. Will the COVID-19 pandemic reduce or accelerate that spending? Sherry Glied, PhD, Dean and Professor of Public Service at New York University, explains. Recorded Monday, April 27, 2020.

Read the article

The Potential Effects of Coronavirus on National Health Expenditures

Don Berwick, MD, MPP, of the Institute for Healthcare Improvement, discusses choices societies and the medical profession can make to improve health care and reduce inequities as we move out of the acute phase of the coronavirus pandemic.

Interview with Paul J. Young, PhD, author of When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?

Safianowicz, Katarzyna Marta, author

Hill, J., author

Koch, Thomas D, author

Australia. Parliament. Senate. Environment and Communications References Committee

Carolan, Michael S

Allen, Simon James, author

Hillel, Daniel, author

Longo, Stefano, author

Pember, Mat, author

Dunlop, Judy, author

Cottingham, Alan, author

Hill, Yvette Joan, author

Isbell, R. F. (Raymond Frederick), 1928-2001, author

Nyland, Ralph D

Shah, Ramisah Mohd, author